WCN25-499 PATIENT BASELINE CHARACTERISTICS IN THE ONGOING PHASE 3 VISIONARY TRIAL: A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF SIBEPRENLIMAB FOR IMMUNOGLOBULIN A NEPHROPATHY

WCN25-499 PATIENT BASELINE CHARACTERISTICS IN THE ONGOING PHASE 3 VISIONARY TRIAL: A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF SIBEPRENLIMAB FOR IMMUNOGLOBULIN A NEPHROPATHY

Saved in:
Bibliographic Details
Main Authors: Richard Lafayette, Hernan Trimarchi, Jonathan Barratt, Kevin Carroll, Vladimír Tesar, Hong Zhang, Yusuke Suzuki, Adrian Liew, Muh Geot Wong, Lokesh Shah, Jing Xia, Cecile Fajaro, Jeffrey Hafkin, Vlado Perkovic
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924023507
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items